Revenue
No reported data
Aura Biosciences, Inc. (AURA)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Research & development | $90.3M | $73.3M | $65.2M | $42.2M | $25.2M | $18.0M |
| Operating expenses | $112.8M | $96.1M | $85.0M | $60.3M | $35.3M | $22.2M |
| Operating income | −$112.8M | −$96.1M | −$85.0M | −$60.3M | −$35.3M | −$22.2M |
| Net income | −$106.2M | −$86.9M | −$76.4M | −$58.8M | −$35.3M | −$22.2M |
| Basic EPSper diluted share | -$1.76 | -$1.75 | -$1.93 | -$1.96 | -$8.95 | -$82.06 |
| Diluted EPSper diluted share | -$1.76 | -$1.75 | -$1.93 | -$1.96 | -$8.95 | -$82.06 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 16, 2026Form 4 | Gibney Anthony SSee Remarks | SellCommon Stock | 12.8K | $6.42 | $82.3K | 265.4K |
| May 7, 2026Form 4 | Matrix Capital Management Company, LP +1TenPercentOwner | SellCommon Stock, par value $0.00001 per share (Common Stock) · indirect | 6.92M | $5.64 | $39.04M | 0 |
| Apr 16, 2026Form 4 | Kilroy ConorSee Remarks | SellCommon Stock | 11.7K | $7.02 | $82.4K | 217.8K |
| Feb 17, 2026Form 4 | Kilroy ConorSee Remarks | SellCommon Stock | 12.1K | $5.05 | $61.0K | 167.2K |
| Feb 17, 2026Form 4 | Plavsic MarkChief Technology Officer | SellCommon Stock | 15.9K | $5.05 | $80.2K | 181.4K |